Vioxx may return to Canadian market if requested?
Health Canada has received seven reports of suspected adverse drug reactions associated with cimicifuga [black cohosh] over the period 1 Jan 1998 to 28 Feb 2005,
Canadian Depo-Provera label updated with risk of BMD loss
Canadian requirements for WBC monitoring for patients receiving Clozaril [clozapine] tablets have not changed,
US Viagra, Cialis and Levitra labels to include reports of vision loss
Janssen, L.P., have issued a 'Dear Health Care Professional' letter informing of changes to the US Duragesic [fentanyl transdermal system] label.
Health Canada has received four reports of Duragesic [fentanyl] patch abuse by boys aged 14−17 years, between 1 Jan 1998 and 31 Jan 2005,
Health Canada has received four reports of suspected ibuprofen-associated Stevens-Johnson syndrome between 1 Jan 1973 and 21 Feb 2005,
There appears to have been an increase in the number of deaths resulting from abuse of prescribed fentanyl patches,
Oxybutynin appears to decrease accommodation amplitude, tolterodine appears to increase mean pupillary diameter in dim light,
Glucocorticoids: greater AE costs
The use of antipsychotics or concomitant use of psychotropics is associated with an increased mortality rate in elderly patients with dementia,
Sulphonylurea monotherapy may be associated with a significantly greater risk of cancer-related mortality than metformin ± sulphonylureas
One-year bodyweight changes appear to vary with different antihyperglycaemics in patients with type 2 diabetes mellitus,
Oral glucosamine appears to increase insulin resistance in patients without diabetes mellitus,
Some NSAIDs may increase breast cancer risk
Antiretrovirals
Baclofen overdose
BCG vaccine
Asparaginase
Dextromethorphan abuse
Botulinum toxin A
Ethinylestradiol/cyproterone
Clozapine
Ezetimibe
Ethionamide
Gemcitabine interaction
Glimepiride
Infliximab
Imatinib
Infliximab
Levofloxacin interaction
Irbesartan/hydrochlorothiazide
Interferon-α-2a/interferon-α-2b
Loperamide
Linezolid
Lidocaine
Mirtazapine
Mefloquine
Mesalazine
Perindopril
Quetiapine withdrawal
Rosiglitazone
Propranolol
Thalidomide